Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Orlistat enhances warfarin effect.

Ronald S MacWalter1, Hazel W Fraser, Katherine M Armstrong

  • 1Stroke Studies Centre, Ninewells Hospital and Medical School, Dundee, Scotland. ronald.macwalter@tuht.scot.nhs.uk

The Annals of Pharmacotherapy
|March 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissociation of response variability from firing rate effects in frontal eye field neurons during visual stimulation, working memory, and attention.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2012
Same author

Persistence, adherence and outcomes with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort.

Cerebrovascular diseases (Basel, Switzerland)·2012
Same author

Mental practice with motor imagery in stroke recovery: randomized controlled trial of efficacy.

Brain : a journal of neurology·2011
Same author

Probing neural circuitry and function with electrical microstimulation.

Proceedings. Biological sciences·2011
Same author

Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage.

Stroke·2010
Same author

Stimulus onset quenches neural variability: a widespread cortical phenomenon.

Nature neuroscience·2010
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Adding orlistat to warfarin therapy may increase the international normalized ratio (INR). This drug interaction necessitates careful monitoring and potential warfarin dose adjustments in patients.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Interactions

Background:

  • Warfarin is a common anticoagulant for atrial fibrillation.
  • Orlistat is used for weight reduction.
  • Managing warfarin therapy requires careful attention to various influencing factors.

Observation:

  • A patient on stable warfarin therapy experienced an elevated international normalized ratio (INR) after initiating orlistat for weight loss.
  • No other medication or condition changes were noted.
  • The Naranjo probability scale indicated orlistat as a probable cause.

Findings:

  • Orlistat use may reduce vitamin K absorption, potentially lowering warfarin requirements.
  • Dietary changes, such as reduced fat intake, associated with orlistat may also affect vitamin K levels.

Related Experiment Videos

  • Concurrent use of orlistat and warfarin requires caution and monitoring.

    • Implications:

    • Clinicians should be aware of the potential for orlistat to alter warfarin's anticoagulant effect.
    • Patients on combined therapy need close INR monitoring and possible warfarin dose adjustments.
    • This interaction highlights the complexity of managing anticoagulation in patients using multiple medications.